Recently, our group created an OVV used to deliver membrane-bound phosphoinositol glycan-linked IL-2 into the TME.67 This allowed local delivery of IL-2 into tumor tissues with reduced systemic toxicity. This evidence concerns the gene IL2 and neoplasm.